Collectively, these findings elucidate ERRα’s pivotal role in safeguarding mitochondrial integrity within PTCs amidst DKD, endorsing the strategic overexpression of ERRα as a potential therapeutic avenue for mitigating mitochondrial‐related injuries in DKD. This evidence concerns the gene ESRRA and diabetic kidney disease.